BioVie Chief Medical Officer Dr. Joseph Palumbo joins Natalie Stoberman from the Proactive newsroom to share the company's latest research and social impact on cognitive diseases to bring awareness to Alzheimer's & Brain Awareness Month.
Dr. Palumbo says BioVie's latest research has shown improvements in motor behaviour for Parkinson's patients, reversing the "off state" experienced by some individuals. In addition, Dr. Palumbo explains there have also been observations of interesting effects on gene methylation and reversing stress-related changes in DNA. BioVie's research also focuses on the metabolic aspects of these diseases and their impact on cognition.
The company has made social impact investments, including donations to organizations and partnering with universities for research initiatives. BioVie is dedicated to treating age-related diseases and expects to provide data from their studies by the end of the year.